Epidermal stem cells markers: p63 (keratinocytes stem cells) and CD 29 (keratinocytes stem and transient amplifying cells), as well as PCNA (Proliferating cell nuclear antigen), were used to determine the regenerative potential of transplanted KCs. Here, PCNA is linked to dry eye syndrome.